Please assess the completion status of the following clinical trial:

Trial Title: MultiPoint Pacing Mapping Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Be scheduled to undergo or have received within the past 30 days an implant of a SJM (St. Jude Medical) MPP CRT-D system with approved standard indication by ESC (European Society of Cardiology) / EHRA (European Heart Rhythm Association) Guidelines~* Have the ability to provide informed consent for study participation and be willing and able to comply with the Clinical Investigation Plan (CIP) described evaluations and follow-up schedule~* Be in sinus rhythm~Exclusion Criteria:~* Complete AV (atrioventricular) block~* Permanent atrial fibrillation~* Have a recent myocardial infarction within 40 days prior to enrollment~* Have undergone cardiac surgery or coronary revascularization procedure within 3 months prior to enrollment or be scheduled for such procedures in the following 7 months~* Have had a recent CVA (cerebrovascular accident) or TIA (transient ischemic attack) within 3 months prior to enrollment~* Have had intravenous inotropic support in the last 30 days~* Be less than 18 years of age~* Be pregnant or plan to become pregnant over the next 7 months~* Have significant peripheral vascular disease~* Have LV thrombus~* Significant aortic valve disease or replacement~* Mitral valvular disease~* Contraindicated for Gadolinium contrast agent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).